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measures following intervention. Among responders, there was a small
decrease in within person change in mechanical detection threshold
(25.1, SD ¼ 69.1), indicating increased sensitivity, while in non-res-
ponders there was a small increase indicating decreased sensitivity
(22.4, SD ¼ 61.8) with a signiﬁcant difference between responders and
non-responders (p ¼ 0.04). There was no other signiﬁcant within per-
son change in any of the QST measures by responder status.
Conclusions: In this small interventional study, patients with higher
sensitivity to mechanical pain were more likely to respond to intra-
articular steroid therapy.
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Purpose: The Ehlers–Danlos Syndrome (EDS) is one the most prevalent
heritable connective tissue disorders. Generalized severe joint hyper-
mobility, which is frequently associated with joint dislocations, chronic
joint and limb pain, and premature osteoarthritis, are the dominant
clinical manifestations of the hypermobility type of EDS (EDS-HT).
Chronic widespread pain is highly present in this patient group, but up
to now, evidence for generalized hyperalgesia is lacking. Several studies
in chronic pain disorders examined whether central hyperexcitability
could be existent by using algometry.
Therefore, the primary objective of the study was to investigate
whether pressure pain thresholds (PPTs) at both symptomatic and
asymptomatic body areas differ in EDS-HT patients compared to
healthy subjects. In addition, we examined the type of chronic pain
EDS-HT patients experience.
Methods: Twenty-three women with EDS-HT and 23 gender- and age-
matched healthy controls participated. All subjects marked on Margolis
Pain Diagram where they felt pain lasting longer than 24 hours in the
past 4 weeks. Then, they completed several questionnaires assessing
pain cognitions (Pain Catastrophizing Scale, Pain Vigilance and
Awareness Questionnaire, Hospital Anxiety and Depression Scale),
fatigue (Checklist Individual Strength subscale fatigue), disability
(Health Assessment Questionnaire), and general health status (Short
Form Health Survey-36), in order to take the possible inﬂuence of these
factors on PPTs into account. Patients also completed the Pain Detect
Questionnaire regarding the severity, course, quality and nature of the
pain they experienced. Thereupon, a blinded researcher assessed PPTs
at 14 body locations on the trunk and extremities. The pressure was
gradually increased at a rate of 1 kg/s until the subject indicated that the
pain level has been reached. The threshold was determined as the mean
of the 2 last values out of the 3 consecutive measurements. This method
has been found to be efﬁcient and reliable in the exploration of path-
ophysiological mechanisms involved in pain. PPTs were compared for
the 2 complete groups. In addition, PPTs of patients and controls who
did not report pain in a respective zone were compared.
Results: The EDS-HT patient group demonstrated signiﬁcantly lower
PPTs compared to the control group for all zones. The mean (SD) PPT
was 2.9 (1.62) kg/cm2 in the EDS-HT patients and 5.2 (1.88) kg/cm2 in
the controls (P < 0.001). Also at asymptomatic (pain-free) zones, EDS-
HT patients systematically showed signiﬁcantly lower pain thresholds
compared to the healthy subjects. No confounding factors responsible
for the observed differences could be revealed.
According to the Margolis Pain Diagram, EDS-HT patients experienced
pain on an average of 31% (17.8) of their body surface, compared to 1%
(2.4) in the control subjects. Furthermore, approximately 40% of the
patients presented with a nociceptive pain pattern, whereas in about
50% a predominantly neuropathic pain component was likely present.
Conclusion: This study shows that several forms of pain coexist in
EDS-HT which are likely the result of different pain-triggering mech-
anisms. The widespread pain lacking local distinction together with
the lower PPTs in body zones outside and remote to the symptomaticzone provide evidence for the existence of generalized secondary
hyperalgesia in patients with EDS-HT, which may represent the
involvement of a sensitized central nervous system as an important
mechanism in the chronic pain problems of this challenging patient
group.
735
PREDICTIVE VALIDITY OF THE PAIN BELIEF SCREENING INSTRUMENT
FOR ESTIMATING PAIN RESPONSIVENESS TO THERAPY
J.H. Abbott y, F. Dobson z, K.L. Bennell z. yUniv. of Otago, Dunedin, New
Zealand; zUniv. of Melbourne, Melbourne, Australia
Purpose: To assess the predictive validity of the Pain Belief Screening
Instrument (PBSI) for predicting clinically meaningful change in
patient-perceived pain following conservative non-drug therapy; and
to establish a cut-off value that distinguishes patients at risk of not
achieving meaningful pain reduction following intervention (exercise
therapy and/or manual therapy).
Methods: We used data from 308 patients in two randomized clinical
trials (RCTs) of people with hip or knee osteoarthritis (OA), at baseline
and 6-month follow-up. Pain was assessed using a numeric pain rating
scale (NPRS) in one RCT and a visual analog scale (VAS) in the second
RCT. From recent literature we considered the minimum clinically
important difference (MCID) to be 2 points on a 0–10 scale. To deter-
mine the association between baseline PBSI and clinically important
change in pain at 6-month follow-up we used a three-phase approach:
ﬁrst using development data set, then an establishment dataset and
subsequently a validation dataset, we estimated area under the curve
(AUC) and parsimonious cut-point, using receiver operating character-
istics (ROC) analyses, and predicted change in pain using linear
regression.
Results: The data sets included 90 patients with hip OA in the devel-
opment set, 116 patients with knee OA in the establishment set and 102
patients with hip OA in the validation set, The cut point on the PBSI (0–
40 scale) was 27, 27 and 26 in the development, establishment and
validation sets, respectively. The AUC for PBSI was .70, .70 and .65 in the
development, establishment and validation sets, respectively. Regres-
sion of change in patient-perceived pain scores was statistically sig-
niﬁcant in all data sets (p < 0.05), but not clinically signiﬁcant, with the
cut-point associated with a difference in pain change of 1.3 points in the
development set, 1.2 points in the establishment set, and 1.3 points in
the validation set.
Conclusions: The PBSI demonstrated some predictive validity for esti-
mating 6-month pain responsiveness to therapy, however the mean
magnitude of difference in pain, between patients scoring above versus
below these ROC-derived cut-points, did not reach the minimum clin-
ically important difference, and the AUC values indicated onlymoderate
accuracy. Despite a high level of consistency among the three datasets,
the lack of clinically important difference in pain outcome suggests that
this information is unlikely to be useful for targeting therapy, however
it may be useful for statistically adjusting for variables associated with
outcome in clinical research.
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Purpose: The Ehlers–Danlos Syndrome (EDS) is the most prevalent
heritable connective tissue disorder. More than 90% of individuals are
classiﬁed as having the hypermobility type (EDS-HT). Patients typically
demonstrate generalized severe joint hypermobility, which is fre-
quently associated with recurrent joint dislocations and premature
osteoarthritis. Although pain is the number one complaint in EDS-HT,
causing severe disability in daily life, the underlying pain mechanisms
and the nature of pain are unknown. Therefore, this study aims to assess
the nature of pain (nociceptive / neuropathic / dysfunctional pain) and
the endogenous pain modulation in EDS-HT.
